AbbVie Inc. Profile Avatar - Palmy Investing

AbbVie Inc.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psori…
Drug Manufacturers - General
US, North Chicago [HQ]

News

Theses · Events · Sentiments
Sentiments
24-11-15 0.00%

The drugmaker has convincingly laid to rest the biggest threat to its top line.

24-11-08 16.60%

You can be a little greedy sometimes and find great stocks that possess solid growth prospects and also pay dividends.

24-10-18 40.00%

These stocks trade at less than 20 times their estimated future profits.

End of ABBV's Analysis
CIK: 1551152 CUSIP: 00287Y109 ISIN: US00287Y1091 LEI: - UEI: -
Secondary Listings